Skip to main content
. 2019 Oct 9;10:2395. doi: 10.3389/fimmu.2019.02395

Figure 1.

Figure 1

Patients with glioma display a stepwise immune deficiency in accordance with the grade classification. (A) PBMCs from 31 healthy donors (HD) and 117 patients (Patient) were evaluated by flow cytometry for CD3, CD19, and CD56 after gating lymphocytes. (B) The percentages of CD3+, CD19+, and CD56+ cells were quantified. (C) The expression of CD3+ decreased in accordance with the grade. (D) Comparisons of the percentages of CD3+, CD19+, and CD56+ cells across the grades are shown. Values shown are means ± SEM (bars); *p < 0.05, #p < 0.01 by Student's t-test.